Related Experiment Video
Updated: Aug 2, 2026
06:10
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
Published on: March 30, 2020
Ion exchange resins for ophthalmic delivery
Journal of Ocular Pharmacology
|January 1, 1994
Summary
A novel ophthalmic drug delivery system using ion exchange resin particles enhances ocular comfort and bioavailability for the antiglaucoma agent Betaxolol Hydrochloride. This system allows for a reduced drug concentration, improving patient tolerance and therapeutic efficacy.
Area of Science:
- Ophthalmology
- Pharmaceutics
- Drug Delivery Systems
Background:
- Glaucoma treatment requires effective drug delivery to the eye.
- Conventional ophthalmic solutions can cause discomfort due to free drug molecules.
- Improving ocular comfort and bioavailability is crucial for sustained glaucoma management.
Purpose of the Study:
- To develop and evaluate a novel ophthalmic drug delivery system for Betaxolol Hydrochloride.
- To enhance ocular comfort and optimize the bioavailability of the antiglaucoma agent.
- To create a stable and easily resuspendable ophthalmic suspension.
Main Methods:
- Utilized ion exchange resin particles for drug binding and release of Betaxolol.
- Conducted in-vitro release studies and analyzed drug-resin interactions.
- Formulated a structured vehicle with Carbomer 934P for physical stability.
- Adjusted zeta potential for particle flocculation and suspension characteristics.
Main Results:
- The novel delivery system significantly enhanced ocular comfort by reducing free drug availability.
- Optimized bioavailability of Betaxolol was achieved, allowing for a 50% reduction in drug concentration.
- The formulation demonstrated good physical stability and uniform dosage characteristics.
- Clinical trials and animal models confirmed bioequivalency and increased comfort compared to conventional solutions.
Conclusions:
- The developed ion exchange resin-based delivery system offers an improved method for administering Betaxolol Hydrochloride.
- This formulation provides enhanced bioavailability and ocular comfort at a reduced drug concentration.
- The product has received FDA approval and is a viable option for glaucoma management.
Related Concept Videos
01:17Ion Exchange
Ion exchange chromatography separates charged molecules from a solution by reversibly exchanging them with mobile, or 'active', ions associated with the oppositely charged stationary phase. This method can be used to separate ions, soften and deionize water, and purify solutions. The polymers comprising the ion-exchange column are high-molecular-weight and chemically stable polymers, crosslinked to be porous and essentially insoluble. They are also functionalized with either acidic or basic...
01:09Ion-Exchange Chromatography
Ion-exchange chromatography, or IEC, is a technique for separating ions based on their affinity for the stationary phase. The stationary phase is a cross-linked polymer resin with covalently attached ionic functional groups. The functional groups can be either positively charged (cation exchangers) or negatively charged (anion exchangers). A cation exchanger consists of a polymeric anion and active cations, while an anion exchanger is a polymeric cation with active anions. The choice of...
01:17Pore Transport and Ion-Pair Transport
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...